Delivery Order SPE2DB22D9367-SPE2DB25FSY29
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $97,437.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Adcetris 50 mg vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The delivery order...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $40,598.90 to DMS Pharmaceutical Group Inc. for the supply of Adcetris 50 mg vials. The contract, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, represents a discrete procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. This delivery order carries no set-aside designation, allowing the woman-owned small business to compete on an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $48,718.74 to DMS Pharmaceutical Group Inc. for the supply of Adcetris 50 mg vials, with an ultimate completion date of September 22, 2025. This delivery order was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's ongoing pharmaceutical supply relationship with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $61,258.56 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 50 mg vials of the pharmaceutical drug ADCETRIS, with a period of performance through December 27, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the...
- On September 29, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $113,676.92 to DMS Pharmaceutical Group Inc. for the supply of Adcetris 50 mg vials. This firm fixed-price delivery order, which carries an ultimate completion date of October 21, 2025, represents a continuation of the company's pharmaceutical supply relationship with the federal government. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 29, 2025, for the supply of Adcetris 50 mg vials, an oncology medication. The contract carries a ceiling value of approximately $64,054 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. This award was funded by the Defense Logistics Agency's Medical Supply Chain division and includes...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 firm fixed-price contract is for the procurement of ADCETRIS 50 MG vials, with a period of performance through May 22, 2024. DMS Pharmaceutical Group holds a single-award, indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,971.96 firm fixed-price contract is for the delivery of 4,564,000,716 units of the drug ADCETRIS (brentuximab vedotin) 50 mg vials. The contract has an ultimate completion date of April 1, 2024. This award is under a larger $4,999,999 indefinite delivery contract the DLA has with DMS...
- This is a firm fixed-price delivery order valued at $45,943.92, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,718.68 for 50 mg vials of Adcetris, an oncology treatment used in cancer therapy. The award, issued on September 16, 2025, with an ultimate completion date of October 14, 2025, carries no set-aside designation and represents a delivery order under the company's larger Indefinite Delivery Contract with the Defense...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSY29Delivery Order
The Defense Logistics Agency awarded a $64,958.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Adcetris (brentuximab vedotin) 50 mg vials. The contract, effective May 30, 2025, with ultimate completion by June 23, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Adcetris, an oncology therapeutic, aligns with DMS Pharmaceutical Group's established portfolio of specialty medications and branded pharmaceutical products delivered to Department of Defense healthcare sites. As a registered woman-owned small business in SAM.gov since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in federal pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.0k | 5/30/25 |